About Matthew Frankel
Matthew Frankel is a chief medical officer at Nocion Therapeutics.
Matthew Frankel reports to the SEC as an officer of 1 public company: Chemomab Therapeutics (CMMB).
Matthew Frankel first appears on SEC filings in 2022.
Experience
This experience comes from Matthew Frankel's profile and from SEC filings. For roles taken from filings, the years are when the filings name Matthew Frankel in the role, so the role may have started earlier or lasted longer.
Nocion Therapeutics, Inc. Current
Chief Medical Officer
2025 – Present · Watertown, MA
Develops inhaled medicines for people with chronic cough.
CL
Chemomab Therapeutics Ltd.
Chief Medical Officer (CMO)
2022 – 2025 · Public company (CMMB)
BI
Boehringer Ingelheim
Vice President, Clinical Development and Medical Affairs, Specialty Care
2018 – 2022
NO
Novartis
VP & Head of Immunology and Dermatology Medical Unit
2016 – 2018
SA
Sandoz
Executive Director, Medical Affairs
2012 – 2016
RP
Reata Pharmaceuticals
Global Medical Director, Clinical Development
2010 – 2012
FI
FibroGen
Medical Director, Clinical Development
2009 – 2010
FB
Facet Biotech
Medical Director, Clinical Development
2005 – 2009
SP
Schering Plough
Medical Science Liaison, Medical Affairs
2002 – 2005
Key Colleagues at Startups
The people Matthew Frankel works with at each company, as listed on that company's latest Form D.
Nocion Therapeutics, Inc. · Form D, Mar 13, 2026
VM
Vijay Murthy
Director
JG
Julie Grant
Director
PO
Pini Orbach
Director
RH
Rosy Hu
Director
Peter Courossi
Acting Chief Financial Officer
Richard Batycky
President and Chief Executive Officer, director
JE
James Ellis
Chief Scientific Officer
FD
Freddie Dear
Director
MH
Michael Higgins
Director